Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19: interim guidance, first issued 19 May 2022


The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF